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Abstract 
The dangling carboxylic acid moiety of the known platinum(II) complex, [Pt(edma)Cl2] (edma = 
ethylenediaminemonoacetic acid), was functionalized via amide coupling chemistry with benzyl 
amine and dansyl ethylenediamine to afford the derivatives [Pt(edBz)Cl2] (1) and [Pt(edDs)Cl2] 
(2).  Subsequent oxidation of these platinum(II) complexes with iodobenzene dichloride in DMF 
yielded the respective platinum(IV) analogues, [Pt(edBz)Cl4] (3) and [Pt(edDs)Cl4] (4).  All four 
platinum complexes were characterized by multinuclear NMR spectroscopy, IR spectroscopy, 
electrospray ionization mass spectrometry, and elemental analysis.  In addition, compounds 1 
and 3 were structurally characterized by X-ray crystallography.  The photophysical properties of 
the compounds bearing the fluorescent dansyl moiety, 2 and 4, were evaluated.  The emission 
quantum yields of 2 and 4 in DMF are 27% and 1.6%, respectively.  This large difference in 
emission efficiency indicates that the platinum(IV) center in 4 is more effective at quenching the 
dansyl-based fluorescence than the platinum(II) center in 2.  Time-dependent density functional 
theory calculations indicate that 4 has several low-lying singlet excited states that energetically 
lie below the primary radiation-accessible excited state of the dansyl fluorophore.  These low-
energy excited states may offer non-radiative decay pathways that lower the overall emission 
quantum yield.  Treatment of 4 with biologically relevant reducing agents in pH 7.4 phosphate-
buffered saline induces a 6.3-fold increase in emission intensity.  These results demonstrate that 
4 and future derivatives thereof may be useful for imaging the reduction of platinum(IV) 
complexes in living systems, chemistry of importance for future platinum-based anticancer drug 
strategies. 
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1. Introduction 
 Platinum-based drugs are effective agents for a number of different cancers [1, 2].  Dose-
limiting toxic side effects and acquired resistance, however, limit the broader applicability of this 
class of compounds.  The search for new platinum anticancer agents with fewer such drawbacks 
is an active area of research [3, 4].  Among the new classes of platinum compounds explored, 
octahedral platinum complexes in the +4 oxidation state show considerable promise.  
Platinum(IV) anticancer complexes have several advantages over first- and second-generation 
square-planar platinum(II) analogues [5-7].  The additional two ligand-binding sites enable 
synthetic modification and fine tuning of the pharmacokinetic parameters.  Compared to 
platinum(II) complexes, however, the mechanism of action of platinum(IV) complexes is less 
well understood.  In most cases, these complexes are best reduced first by two electrons to form 
square-planar platinum(II) complexes in a process that facilitates binding to proteins, DNA, or 
other cellular targets [8].  Still, questions remain about this reductive activation step.  It is not 
clear as to how quickly, by what means, and where such reduction occurs in living systems.  X-
ray fluorescence and absorption spectroscopy [9-11] has been used to address these questions.  
These methodologies, however, are not applicable to live cells and generally require synchrotron 
radiation. 
Optical fluorescence microscopy for imaging analytes and processes in living systems is 
well established [12].  This method has been used to study the cellular localization and uptake of 
platinum-fluorophore conjugates, which were designed as models for related platinum anticancer 
drugs [13-15].  Although fluorescence microscopy, unlike X-ray techniques, cannot directly 
provide information about the oxidation state of metal ions, it is possible to apply ligand systems 
in which the fluorescence intensity is modulated depending on the oxidation state of the 
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coordinated metal [16, 17].  Such a system involving the Pt(IV)/Pt(II) redox couple has recently 
been described [18], in which analogous platinum(II) and platinum(IV) complexes were 
coordinated to fluorescent coumarin ligands by means of an aniline functional group on the dye.  
The authors reported a 7-fold greater emission intensity for the platinum(II) compared to the 
platinum(IV) complex in DMF solution.  Furthermore, confocal fluorescence microscopic 
imaging analyses revealed strong localization of the complexes in the cytosol and lysosomes.  
The free coumarin ligands exhibited cellular localization similar to that of the complexes, thus 
raising the possibility that the coumarin ligands are displaced from platinum in the cell.  Similar  
systems with strongly coordinated bidentate ligands may be able to provide information about 
platinum(IV) reduction in live cells. 
In the present article we describe our work to design a platinum-fluorophore conjugate 
that can be used to monitor platinum(IV) reduction in living systems by an emissive turn-on 
response.  We present the synthesis and characterization of the dansyl fluorophore-bearing 
platinum(II) and platinum(IV) complexes, 2 and 4, as well as non-fluorescent analogues 1 and 3 
(Scheme 1).  Photophysical studies of 2 and 4 indicate the platinum(IV) complex to have a 
significantly lower emission quantum yield than the platinum(II) complex; upon reduction of 4, a 
6.3-fold emission turn-on response is observed in aqueous buffer.  Additionally, computational 
studies are reported that rationalize the increased fluorescence quenching of 4. 
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Scheme 1 
 
2. Experimental Section  
2.1. General Considerations  
All reactions were carried out under normal atmospheric conditions.  Solvents were used 
as received without additional drying or purification.  The compounds, [Pt(edma)Cl2] (edma = 
ethylenediaminemonoacetic acid) [19], dansyl ethylenediamine (Ds-en) [20], and iodobenzene 
dichloride [21], were synthesized as previously described.  Benzylamine and 
carbonyldiimidazole (CDI) were purchased from Sigma Aldrich and used as received. 
2.2. Physical Measurements 
NMR spectra were recorded on a Bruker DPX-400 spectrometer in the MIT Department 
of Chemistry Instrumentation Facility at 20 °C.  1H and 13C{1H} NMR spectra were referenced 
internally to residual solvent peaks, and chemical shifts are expressed relative to 
tetramethylsilane, SiMe4 (δ = 0 ppm).  195Pt{1H} NMR spectra were referenced externally to 
K2PtCl4 in D2O (δ = -1628 ppm).  NMR spectra of all compounds are shown in the 
Supplementary Data (Figs. S1–S22).  Fourier transform infrared (FTIR) spectra were recorded 
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with a ThermoNicolet Avatar 360 spectrometer running the OMNIC software.  Samples were 
prepared as KBr disks.  Cyclic voltammograms were obtained at room temperature using a 
VersaSTAT3 potentiostat from Princeton Applied Research accompanied by the V3 Studio 
software.  A three-electrode system was used, comprising a glassy carbon working electrode, a 
Pt wire auxiliary electrode, and a Ag/AgCl (aqueous saturated NaCl) reference electrode.  
Samples were prepared as 2 mM solutions in DMF with 0.1 M (Bu4N)(PF6) as the supporting 
electrolyte.  Peak potentials are reported at a scan rate of 100 mV/s.  The ferrocene/ferrocenium 
redox couple was 0.54 – 0.55 V vs Ag/AgCl using the setup described here.  Optical absorption 
spectra were recorded with a Cary 1E spectrophotometer.  Emission spectra were obtained with a 
Photon Technology International QM-4/2003 fluorimeter.  Quantum yields for fluorescence were 
measured using quinine sulfate in 0.1 M H2SO4 (Φ = 0.58) as the reference [22] over a range of 
at least five different absorbance values.  For measuring these values in phosphate buffered 
saline (PBS), the samples were diluted from DMF solutions to give aqueous solutions containing 
less than or equal to 1% DMF.  For all photophysical measurements, the sample temperature was 
maintained at 25.0 ± 0.5 °C using a circulating water bath. 
2.3. Synthesis of [Pt(edBz)Cl2] (1) 
A solution of CDI (0.230 g, 1.42 mmol) in 10 mL of DMF was added to a solution of 
[Pt(edma)Cl2] (0.535 g, 1.39 mmol) in 10 mL of DMF.  The resulting mixture was heated at 60 
°C for 10 min, and then sparged with N2 for 5 min.  Benzylamine (0.152 g, 1.42 mmol) in 15 mL 
of DMF was added dropwise to the solution containing the activated platinum complex.  After 
stirring for 12 h, the solution was concentrated to 10 mL under reduced pressure and elevated 
temperature (60 °C) and then filtered through Celite.  The addition of 10 mL of water afforded 
the desired compound as a pale yellow solid, which was isolated by filtration and washed 
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sequentially with 5 mL of water, 2 × 5 mL of ethanol, and 2 × 5 mL of diethyl ether before being 
dried in vacuo.  Yield: 0.268 g (40%).  M.p. 298–300 °C (dec).  1H NMR (400 MHz, DMF-d7): δ 
8.60 (t, 1H), 7.35 – 7.26 (m, 5H), 6.15 (br s, 1H), 5.48 (br s, 2H), 4.43 (d, 2H), 4.27 (d, 1H), 3.71 
(dd, 1H), 3.12 – 3.07 (br m, 1H), 2.82 – 2.72 (br m, 2H), 2.57 – 2.55 (br m, 1H).  13C{1H} NMR 
(100 MHz, DMF-d7): δ 168.2, 139.4, 128.6, 127.7, 127.2, 57.8, 55.1, 47.3, 42.8.  195Pt{1H} NMR 
(86 MHz, DMF-d7): δ -2339.  IR (KBr, cm-1): 3335 m, 3274 s, 3202 m, 2940 w, 1654 vs, 1576 
m, 1545 s, 1455 w, 1436 m, 1425 m, 1392 vw, 1279 w, 1243 m, 1168 w, 1116 w, 1091 w, 1041 
w, 967 w, 758 m, 702 s, 611 w, 572 w, 525 w.  ESI-MS (negative-ion mode): m/z 509.4 [M+Cl]-,  
944.6 [2M–H]-, 980.9 [2M+Cl]-.  Anal. Calcd. for C11H17Cl2N3OPt:  C, 27.92; H, 3.62; N, 8.88.  
Found:  C, 28.30; H, 3.65; N, 8.85. 
2.4. Synthesis of [Pt(edDs)Cl2] (2) 
A solution of CDI (0.206 g, 1.27 mmol) in 20 mL of DMF was added to a solution of 
[Pt(edma)Cl2] (0.469 g, 1.21 mmol) in 16 mL of DMF, and the resulting mixture was stirred at 
60 °C for 10 min.  The solution was sparged with N2 for 5 min, and then Ds-en (0.372 g, 1.27 
mmol) in 20 mL of DMF was added dropwise.  After stirring at r.t. for 12 h, the mixture was 
concentrated to 10 mL under vacuum and increased temperature (60 °C), and then filtered 
through Celite.  Water (10 mL) was added to the filtrate to precipitate the desired compound.  
The pale yellow solid was isolated by filtration, and washed sequentially with water, ethanol, and 
diethyl ether.  Yield: 0.471 g (59%).  M.p. 258–262 °C (dec).  1H NMR (400 MHz, DMF-d7): δ 
8.55 (d, 1H), 8.39 (d, 1H), 8.28 (t, 1H), 8.20 (d, 1H), 7.97 (br t, 1H), 7.68 (t, 1H), 7.62 (t, 1H), 
7.30 (d, 1H), 6.03 (br s, 1H), 5.44 (br s, 2H), 4.12 (d, 1H), 3.49 – 3.45 (m, 1H), 3.29 – 3.26 (m, 
2H), 3,01 – 2.96 (m, 3H), 2.88 (s, 6H), 2.69 (br m, 2H), 2.44 (br m, 1H).  13C{1H} NMR (100 
MHz, DMF-d7): δ 168.4, 152.2, 136.6, 130.01, 129.99, 129.8, 128.9, 128.2, 123.9, 119.7, 115.6, 
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57.7, 55.1, 47.3, 45.2, 42.5, 39.6.  195Pt{1H} NMR (86 MHz, DMF-d7): δ -2345.  IR (KBr, cm-1): 
3351 m, 3270 m, 3192 m, 3141 m, 2946 w, 1659 vs, 1571 w, 1547 w, 1318 s, 1144 s, 1095 w, 
788 s, 629 w, 576 w.  ESI-MS (negative-ion mode): m/z 657.8 [M–H]-.  Anal. Calcd. for 
C18H27Cl2N5O3PtS:  C, 32.78; H, 4.13; N, 10.62.  Found:  C, 32.92; H, 4.12; N, 10.77.  
2.5. Synthesis of [Pt(edBz)Cl4] (3) 
[Pt(edBz)Cl2] (0.120 g, 0.250 mmol) was dissolved in 10 mL of DMF with gentle heating 
at 60 °C.  To this solution, iodobenzene dichloride (0.072 g, 0.26 mmol) in 1 mL of DMF was 
added dropwise.  The solution changed color immediately from pale yellow to bright yellow.  
After stirring 3 h at r.t., a 25 mL portion of diethyl ether was added, and the resulting bright 
yellow solid was collected by filtration.  It was further washed with diethyl ether and then dried 
in vacuo.  Yield: 0.086 g (63%).  M.p. 188–198 °C (dec).  1H NMR (400 MHz, DMF-d7): δ 8.90 
(t, 1H), 7.92 (br s, unresolved 195Pt satellites, 1H), 7.68 (br s, unresolved 195Pt satellites, 1H), 
7.39–7.27 (m, 5H), 7.10 (br s, 2JPtH = 56 Hz, 1H), 4.51–4.43 (m, 3H), 3.93–3.83 (m, 1H), 3.36–
3.20 (br m, 3H), 2.88 (br m, 1H).  13C{1H} NMR (100 MHz, DMF-d7): δ 166.7, 139.2, 128.7, 
127.8, 127.4, 59.2, 54.5, 47.8, 43.2.  195Pt{1H} NMR (86 MHz, DMF-d7): δ -382.  IR (KBr, cm-
1): 3224 m, 3075 m, 3027 m, 2961 w, 1656 vs, 1571 m, 1496 vw, 1453 w, 1409 w, 1329 w, 1298 
w, 1266 w, 1203 vw, 1131 vw, 1098 w, 1048 w, 750 m, 701 m, 662 w, 613 w, 595 w, 575 w.  
ESI-MS (negative-ion mode): m/z 542.5 [M–H]-, 1086.6 [2M–H]-.  Anal. Calcd. for 
C11H17Cl4N3OPt:  C, 24.28; H, 3.15; N, 7.72.  Found:  C, 24.66; H, 3.36; N, 7.43. 
2.6. Synthesis of [Pt(edDs)Cl4] (4) 
A solution of iodobenzene dichloride (0.107 g, 0.390 mmol) in 2 mL of DMF was added 
dropwise to a solution of [Pt(edDs)Cl2] (0.250 g, 0.379 mmol) in 16 mL of DMF.  The color of 
the solution changed immediately from pale yellow to pale orange.  After stirring 12 h at r.t., 80 
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mL of diethyl ether was added to form a sticky residue on the flask bottom.  The diethyl ether 
and DMF were decanted, and 30 mL of water was added to the residue.  The resulting solid was 
collected by filtration.  It was suspended sequentially in water, methanol, and diethyl ether 
before being dried in vacuo.  Yield: 0.103 g (33%).  M.p. 245–254 °C (dec).  1H NMR (400 
MHz, DMSO-d6): δ 8.57–8.53 (m, 2H), 8.41 (d, 1H), 8.23 (d, 1H), 8.01 (t, 1H), 7.90 (br s, 1H), 
7.71–7.61 (m, 3H), 7.32 (d, 1H), 6.92 (br s, 2JPtH = 58 Hz, 1H), 4.35–4.30 (m, 1H), 3.74–3.68 (m, 
1H), 3.37–3.29 (m, 3H), 3.16–3.05 (m, 5H), 2.89 (s, 6H).  13C{1H} NMR (100 MHz, DMF-d7): δ 
166.7, 152.0, 136.6, 130.0, 129.9, 129.8, 128.9, 128.2, 123.9, 119.8, 115.6, 58.9, 54.3, 47.7, 45.2, 
42.3, 40.0.  195Pt{1H} NMR (86 MHz, DMF-d7): δ -386.  IR (KBr, cm-1): 3346 s, 3307 m, 3185 
m, 3075 m, 2956 w, 2872 w, 2790 w, 1688 vs, 1613 w, 1573 m, 1543 m, 1480 w, 1450 m, 1431 
m, 1412 m, 1316 s, 1254 w, 1234 w, 1158 s, 1141 vs, 1085 m, 1063 m, 1041 m, 960 m, 942 m, 
910 w, 839 w, 814 m, 788 s, 681 w, 627 s, 574 s, 554 w, 499 w.  ESI-MS (negative-ion mode): 
m/z 728.5 [M–H]-, 1458.6 [2M–H]-.  Anal. Calcd. for C18H27Cl4N5O3PtS:  C, 29.60; H, 3.73; N, 
9.59.  Found:  C, 29.55; H, 3.71; N, 9.36. 
2.7. Theoretical Calculations 
Density functional theory (DFT) calculations were performed with the Gaussian 03 
(Rev.D01) software package [23].  All calculations were carried out using the B3LYP functional 
[24, 25].  The LANL2DZ basis set and effective core potential [26] was used for the Pt atom and 
the 6-31++G(d,p) basis set [27] was used for all other atoms.  Geometries of 2 and 4 were 
optimized in the gas phase and established as local minima by frequency calculations, which 
revealed no imaginary values.  The conductor-like polarizable continuum model (CPCM) [28] 
was applied for subsequent molecular orbital and time-dependent DFT (TDDFT) calculations to 
simulate solvation of the compounds in water.  The TDDFT calculations were used to determine 
	  	  
9	  
the natures, energies, and oscillator strengths of the 50 lowest energy singlet excited states.  
Relevant Kohn-Sham molecular orbitals, the XYZ-coordinates of optimized structures, and a 
summary the lowest energy (< 4.09 eV, > 303 nm) singlet excited states are provided in the 
Supplementary Data (Figs. S23 and S24, Tables S1–S4).  
2.8. X-ray Crystallographic Studies 
Single crystals of 1·DMF and 3·DMF were grown by vapor diffusion of diethyl ether into 
DMF solutions.  The single crystals were mounted in Paratone oil on a cryoloop and frozen 
under a 100 K KRYO-FLEX nitrogen cold stream.  Data were collected on a Bruker APEX CCD 
X-ray diffractometer with graphite-monochromated Mo-Kα radiation (λ = 0.71073 Å) controlled 
by the APEX2 software package [29].  Absorption corrections were applied using SADABS [30].  
The structures were solved using direct methods and refined on F2 with the SHELXTL-97 
software package [31, 32].  Structures were checked for higher symmetry using PLATON [33].  
All non-hydrogen atoms were located and refined anisotropically.  Hydrogen atoms were placed 
in idealized locations and given isotropic thermal parameters equivalent to either 1.5 (terminal 
CH3 or NH3 hydrogen atoms) or 1.2 times the thermal parameter of the atom to which they were 
attached.  The highest residual electron density peaks and holes after complete refinement were 
located less than 1.33 Å from the platinum atom in the structures of both 1 and 3.  
Crystallographic data collection and refinement parameters are shown in Table 1. 
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Table 1.  X-ray Crystallographic Data Collection and Refinement Parameters. 
 1·DMF 3·DMF 
formula C14H24Cl2N4O2Pt C14H24Cl4N4O2Pt 
fw 546.36 617.26 
space group P21/c P21/c 
a, Å 13.7730(9) 14.4637(8) 
b, Å 12.6440(8) 11.2251(6) 
c, Å 11.2843(7) 13.3621(8) 
β, deg 102.6200(10) 109.8980(10) 
V, Å 3 1917.6(2) 2039.9(2) 
Z 4 4 
ρcalcd, g·cm-3 1.892 2.010 
T, °C -173(2) -173(2) 
μ(Mo Kα), mm-1 7.608 7.418 
θ range, deg 1.52−29.61 1.50−25.05 
total no. of data 41701 31699 
no. of unique data 5382 3604 
no. of parameters 210 228 
completeness to θ (%) 99.8 99.8 
R1a (%) 2.49 3.42 
wR2b (%)  3.95 6.98 
GOFc 1.074 1.086 
max, min peaks, eÅ–3 1.123, -0.447 2.011, -0.894 
a R1 = Σǁ‖Foǀ − ǀFcǁ‖/ΣǀFoǀ. b wR2 = {Σ[w(Fo2 – Fc2)2]/Σ[w(Fo2)2]}1/2. c GOF = {Σ[w(Fo2 – Fc2)2]/(n – p)}1/2 where n is the number of data and p is the 
number of refined parameters. 
 
3. Results and Discussion 
3.1. Synthesis and Characterization 
The platinum(II) complexes, 1 and 2, were prepared by an amide coupling reaction 
between [Pt(edma)Cl2] and benzylamine or Ds-en, respectively (Scheme 2).  This amide 
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coupling reaction can be used to tether other desired amines to the core platinum(II) moiety.  It is 
analogous to the amide coupling chemistry that has been employed to conjugate chemical 
moieties to the platinum(IV) complex, cct-[Pt(NH3)2Cl2(O2CC2H4CO2H)2], a derivative of 
cisplatin [34, 35].  Similar platinum(II) and platinum(IV) complexes bearing ethylenediamine-
N,N’-diester ligands have been reported previously [36].  In these cases, however, the esterified 
ligands were prepared prior to metallation.  For a series of platinum(II) peptide conjugates that 
were synthesized on a solid-phase support, it was necessary to protect the platinum-chelating unit 
during the synthesis of the peptide fragment [37, 38].  The advantage of performing the coupling 
reaction directly on the coordinated ligand, as demonstrated here, is that it eliminates the need 
for protecting groups during organic or peptide synthesis.  We envision that this synthetic 
approach will be general and provide access to a range of interesting functionalized platinum(II) 
complexes. 
Scheme 2 
 
 Clean oxidation of 1 and 2 to their Pt(IV) derivatives was accomplished with the 
hypervalent iodine reagent, iodobenzene dichloride (Scheme 3).  By multinuclear NMR 
spectroscopy, we determined that only the tetrachloroplatinum(IV) complexes 3 and 4 were 
formed.  The use of hydrogen peroxide as the oxidant in either water or acetic acid gave rise to a 
mixture of at least three different platinum(IV) compounds, as revealed by 195Pt NMR 
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spectroscopy.  Alternative hypervalent iodine reagents, PhI(OAc)2, PhI(OH)(OTs), and 2,6-
dimethyliodosylbenzene, failed to oxidize 1 and 2 under similar conditions.  
 
Scheme 3 
 
 Characterization of the platinum complexes was carried out by conventional 
spectroscopic methods.  The starting material for 1 and 2, [Pt(edma)Cl2], has a strong absorption 
in its IR spectrum at 1720 cm-1, which is assigned to the C=O stretching frequency of the 
carboxylic acid.  In 1 and 2, this absorption is replaced by lower energy C=O vibrations at 1654 
and 1659 cm-1, respectively, consistent with the disappearance of the free carboxylic acid and 
formation of an amide bond.  In the IR spectra of 3 and 4, these absorptions occur at 1656 and 
1688 cm-1, respectively.  The presence of the dansyl fluorophore in 2 and 4 was verified by the 
presence of S=O stretching frequencies from the sulfone moiety.  The asymmetric and symmetric 
S=O stretches of 2 occur at 1318 and 1144 cm-1, and those of 4 are at 1316 and 1141 cm-1. 
 The 1H and 13C NMR spectra of 1 – 4 are consistent with the proposed structures.  Peak 
assignments were made using 2-D COSY and 1H,13C-HSQC NMR techniques as detailed in the 
Supplementary Data (Figs. S1 – S22).  The aliphatic regions of the 1H NMR spectra are 
characterized by complex splitting patterns due diastereotopic protons on and near the 
ethylenediamine backbone.  Upon formation of the platinum(IV) complexes, resonances due to 
the coordinated NH and NH2 groups shift downfield, consistent with oxidation of the platinum 
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center (Figure 1).  Additionally, the NH resonances of the coordinated secondary amine in the 
platinum(IV) complexes display satellites arising from coupling to the 195Pt nucleus (I=1/2, 
33%), with 2JPtH = 56 and 58 Hz for 3 and 4, respectively.  Platinum(IV) complexes give rise to 
well-resolved Pt satellites, unlike those of platinum(II) [39].  The 13C NMR spectra display all 
anticipated resonances.  The 195Pt NMR spectra of 1 and 2 reveal resonances at -2339 and -2345 
ppm, respectively.  These values are typical for platinum(II) in an N2Cl2 coordination 
environment [40, 41], and the similarity between them indicates that the peripheral substituents 
on the amide do not significantly affect shielding at the platinum nucleus.  The 195Pt chemical 
shifts of 3 and 4 are -382 and -386 ppm.  These large downfield shifts relative to those of 1 and 2 
are consistent with oxidation to platinum(IV).  As with 1 and 2, their close proximity indicates 
that the electronic environments of the platinum centers are substantially the same. 
 
Fig. 1.  Aromatic region of the 1H NMR spectra of 1 (top) and 3 (bottom) obtained at 20°C and 
400 MHz in DMF-d7.  The asterisk marks the signal due to the solvent. 
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 Single crystals of 1·DMF and 3·DMF were grown by diffusion of diethyl ether into DMF 
solutions of the complexes, and X-ray diffraction analyses revealed their structures, which are 
depicted in Figures 2 and 3.  Relevant bond distances and angles for 1 are given in Table 2.  The 
square-planar geometry and bond lengths are typical of Pt(II) complexes.  A molecule of DMF is 
in the crystal lattice of 1 and forms a hydrogen bonding interaction with the NH group of the 
amide linkage, with ODMF···Namide = 2.83 Å.  Also present in the lattice are short intermolecular 
Pt–Pt interactions (Figure 2, right), marked by a Pt–Pt distance of 3.30 Å.  The X-ray crystal 
structure of the analogous compound, [Pt(en)Cl2] (en = ethylenediamine), has been determined 
for two distinct polymorphs [42, 43].  A careful crystal packing analysis of these polymorphs 
revealed close Pt–Pt intermolecular interactions, similar to those observed for 1.  In the 
orthorhombic form [42], the Pt–Pt separation is 3.38 Å, whereas the Pt–Pt separation in the 
triclinic polymorph [43] is 3.42 Å.  These Pt–Pt interactions are supported by hydrogen bonds 
between the chloride ligands and coordinated amine protons of the neighboring molecules.  The 
reason for the slightly shorter Pt–Pt distance in 1 compared to [Pt(en)Cl2] is not immediately 
obvious. 
 
Table 2.  Interatomic Distances (Å) and Angles (deg) for 1.a  
Bonds  Angles  
Pt(1)-N(1) 2.024(2) N(1)-Pt(1)-N(2) 84.14(7) 
Pt(1)-N(2) 2.0425(18) N(1)-Pt(1)-Cl(1) 90.87(5) 
Pt(1)-Cl(1) 2.3142(5) N(1)-Pt(1)-Cl(2) 174.38(5) 
Pt(1)-Cl(2) 2.3246(6) N(2)-Pt(1)-Cl(1) 174.97(6) 
aNumbers in parentheses are estimated standard deviations in the last significant figures. Atoms are labeled as indicated in Figure 2. 
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Fig. 2.  ORTEP diagrams of 1. The intermolecular Pt-Pt interaction is shown at the right.  
Ellipsoids are drawn at 50% probability levels. 
 
 
Fig. 3.  ORTEP diagram of 3. Ellipsoids are drawn at the 50% probability level. 
Table 3.  Selected Interatomic Distances (Å) and Angles (deg) for 3.a  
Bonds  Angles      
Pt(1)-N(1) 2.017(4) N(1)-Pt(1)-N(2) 83.30(18) N(2)-Pt(1)-Cl(2) 94.22(14) Cl(3)-Pt(1)-Cl(2) 90.09(5) 
Pt(1)-N(2) 2.109(6) N(1)-Pt(1)-Cl(1) 91.12(12) N(2)-Pt(1)-Cl(3) 91.87(14) Cl(4)-Pt(1)-Cl(2) 93.27(5) 
Pt(1)-Cl(1) 2.3041(15) N(1)-Pt(1)-Cl(2) 177.20(12) N(2)-Pt(1)-Cl(4) 85.70(14) Cl(3)-Pt(1)-Cl(4) 175.99(5) 
Pt(1)-Cl(2) 2.3216(14) N(1)-Pt(1)-Cl(3) 88.69(13) Cl(1)-Pt(1)-Cl(2) 91.43(5)   
Pt(1)-Cl(3) 2.3065(14) N(1)-Pt(1)-Cl(4) 87.86(13) Cl(1)-Pt(1)-Cl(3) 91.06(6)   
Pt(1)-Cl(4) 2.3189(14) N(2)-Pt(1)-Cl(1) 173.63(15) Cl(1)-Pt(1)-Cl(4) 91.05(5)   
aNumbers in parentheses are estimated standard deviations in the last significant figures. Atoms are labeled as indicated in Figure 3. 
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The structure of 3 is shown in Figure 3, and relevant bond distances and angles are 
reported in Table 3.  As observed in the crystal structure of 1, a molecule of DMF is present and 
forms a hydrogen bond with the proton of the amide group (ODMF···Namide· = 2.81 Å).  The 
coordination geometry of 3 is octahedral, as expected for a platinum(IV) complex.  The Pt–Cl 
bond distances are close to 2.3 Å at both the axial and the equatorial sites. 
3.2. Electrochemistry 
The cyclic voltammograms of the two platinum(IV) complexes, 3 and 4, were recorded in 
DMF with 0.1 M Bu4N(PF6) as the supporting electrolyte (Figure 4).  The cathodic peak 
potentials measured at a scan rate of 100 mV/s for 3 and 4 are at approximately –0.3 V versus 
Ag/AgCl.  For the analogous compound, cis-[Pt(NH3)2Cl4], the measured peak potential under 
identical conditions is –0.45 V [44].  This result indicates that 3 and 4 are easier to reduce than 
cis-[Pt(NH3)2Cl4], despite similar N2Cl4 coordination sphere.  The presence of electron-
withdrawing amide groups in 3 and 4 may produce this positive shift in the peak potential and 
facilitate their reduction.  
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Fig. 4.  Cyclic voltammograms of 3 (bottom) and 4 (top) measured at a scan rate of 100 mV/s in 
DMF with 0.1 M (Bu4N)(PF6) as the supporting electrolyte.  The potential is reported vs 
Ag/AgCl. 
 
3.3. Photophysical Properties  
The absorption and emission properties of the fluorescent compounds 2, 4, and Ds-en 
were measured in both DMF and phosphate-buffered saline (PBS) at pH = 7.4.  The results are 
summarized in Table 4.  In DMF, the absorption and emission maxima of the three compounds 
are nearly identical.  This result is expected because the optical properties of both compounds are 
dominated by relatively intense π-π* transitions of the dansyl fluorophore.  In moving from 
DMF to water, the absorption maxima of the three compounds are blue-shifted by 10 nm, and the 
emission maxima are red-shifted by approximately 40 nm.  As seen in Table 4, the emission 
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quantum yields depend on both the presence of the platinum center and its oxidation state, as 
well as the solvent.  In DMF, the platinum(II) center of 2 slightly quenches the emission, with 
the quantum yield dropping to 27% from the 40% value measured for free Ds-en.  The relatively 
high quantum yield of 27% is in contrast to prior results from our laboratory in which the 
presence of a platinum(II) center lowered the quantum yield of a dansylated ligand by a factor of 
15 [45].  In the previous system, however, the dansyl fluorophore was positioned much more 
closely to the platinum(II) center.  Quenching of dansyl fluorescence by platinum(II) through the 
heavy-atom effect thus depends on the spatial separation between the two moieties [46].  The 
higher quantum yield of 2 most likely derives from the long distance of the dansyl fluorophore 
from the platinum(II) center.  The emission quantum yield of the platinum(IV) complex, 4, in 
DMF is only 1.6%, significantly less than that of 2.  This result indicates 4 to be a good 
candidate for displaying the desired fluorescence turn-on response upon reduction to Pt(II). 
 
Table 4.  Photophysical Properties of 2 and 4 in DMF and Buffered Aqueous Solution.a 
compound absorption in DMF  
λmax (nm), ε × 103( M-1•cm-1) 
absorption in PBS  
λmax (nm), ε × 103 (M-1•cm-1) 
emission in DMF  
λem (nm), Φ 
emission in PBS  
λem (nm), Φ 
2 339, 4.8(2) 328, 4.6(1) 520, 0.27(1) 560, 0.033(2) 
4 333, 5.19(8) 325, 5.1(1) 520, 0.016(1) 560, 0.0027(9) 
Ds-en 339, 4.7(1) 328, 4.6(1) 520, 0.40(2) 555, 0.032(3) 
aNumbers in parentheses are the standard deviations in the last significant figures derived from at least three 
independent measurements 
 
 
 In moving from DMF to PBS, significant fluorescence quenching occurs for all three 
compounds.  The quantum yields of Ds-en and 2 drop to values of 3.2 and 3.3%, respectively.  
This result is expected because the emission of the dansyl fluorophore depends strongly on 
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solvent polarity [47].  Importantly, the increased quenching effect of the platinum(IV) 
compound, 4, carries over to the aqueous environment where the 0.27% quantum yield for 
emission is still much lower than that of 2.  In water, 4 will therefore elicit a fluorescence turn-on 
response when reduced to platinum(II), as described below. 
3.4. DFT Calculations 
Time-dependent DFT (TDDFT) calculations were performed to gain an understanding of 
the origin of the decreased emission of 4 relative to that of 2.  The frontier molecular orbital 
diagrams of 2 and 4 are shown in Figure 5.  The HOMO for both complexes is a dansyl-based π 
orbital.  The LUMOs of 2 and 4 are different, however.  In the case of 2, the LUMO, like the 
HOMO, is a dansyl-based π orbital.  In 4, the octahedral coordination geometry shifts the 
energies of the dx2-y2 and dz2 metal orbitals to an energy that lies between those of the dansyl-
based occupied and unoccupied orbitals, resulting in a LUMO that is metal-based.  To 
understand how these molecular orbitals affect the photophysical properties of the complexes, 
the 50 lowest energy singlet excited states were computed for both 2 and 4 (Tables S3 and S4, 
Supplementary Data).  Both compounds are computed to have an identical, dansyl-based excited 
state in the visible region (3.32 eV, 373 nm) with a large oscillator strength (f = 0.1741), 
corresponding to the HOMO–LUMO transition for 2 and the HOMO–LUMO+2 transition for 4 
(Fig. 5).  This excited state transition is the only one that is strongly allowed following 
irradiation with visible light (λ > 310 nm, f > 0.01), and it is therefore responsible for emission as 
it relaxes to the ground state. If lower energy excited states are available, however, relaxation can 
occur non-radiatively through them.  In 2 only two excited states, both ligand field (d–d) in 
character, are lower in energy than the allowed HOMO–LUMO transition.  Compound 4, on the 
other hand, has 15 excited states that are lower in energy than its allowed HOMO–LUMO+2 
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transition.  Of these 15, the first and second lowest energy excited states can be described as π 
(dansyl)  σ* (platinum) charge-separated states.  As shown on the right side of Fig. 5 by the 
black downward arrows, these excited states provide plausible non-radiative decay pathways that 
can be rationalized based on molecular orbital energies alone.  These competing non-radiative 
pathways lower the overall quantum yield for emission of 4, relative to that of 2.  
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Fig. 5.  Frontier Kohn-Sham molecular orbital diagram for 2 (left) and 4 (right). 
 
3.5. Response to Reducing Agents 
Figure 6 displays the emission turn-on response induced by treatment of 4 with a 10-fold 
excess of glutathione in PBS at pH 7.4.  Substitution of other biological reducing agents, cysteine 
and ascorbic acid, for glutathione afforded nearly identical results.  The magnitude and speed of 
the turn-on response is the same for the three reducing agents.  Within a minute after addition of 
the reducing agents, the turn-on response is complete, with no further increase in emission for up 
to 15 minutes.  The kinetic behavior of this turn-on response is consistent with the ability of 
ascorbic acid to rapidly reduce a similar compound, [Pt(en)Cl4] [48].  
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Fig. 6.  Emission spectra of 4 before (black line) and after addition of 10-fold excess of 
glutathione (red dashes) in pH 7.4 phosphate-buffered saline.  The small peak at 680 nm arises 
from scattered excitation light (λex = 340 nm). 
 
The turn-on response upon reduction affords a 6.3-fold increase in integrated emission intensity.  
Control experiments were carried out in which 4 was treated with the non-reducing amino acid 
glycine, and the platinum(II) complex, 2, was similarly treated with glycine as well as the three 
biological reducing agents.  The emission of 2 did not change upon introduction of any of the 
four compounds, as anticipated.  When 4 was treated with glycine, a 1.2-fold increase in 
emission was observed after several scans and minutes.  In an additional control experiment, 4 
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alone in buffer showed a similar emission increase after several scans in the fluorimeter.  This 
small but noticeable emission increase most likely arises from photoreduction of 4 in the 
fluorimeter.  Such photoreduction of the metal center is consistent with the proposed 
fluorescence quenching mechanism by which non-radiative relaxation occurs through the 
population of metal-based orbitals. 
 
4. Summary and Conclusions 
 Dansyl-bearing fluorescent platinum(II) and platinum(IV) complexes have been 
synthesized together with non-fluorescent analogues.  The non-fluorescent analogues have been 
crystallographically characterized.  The synthetic methodology employed for the syntheses of 1 
and 2 has sufficient generality to facilitate the preparation of platinum(II) complexes bearing a 
variety of peripheral functional groups.  The simple amide-coupling chemistry employed should 
aid in the development of novel platinum(II) complexes for anticancer screening.  The results of 
our photophysical studies demonstrate selective fluorescence quenching in the platinum(IV), 
compound 4, compared to the platinum(II), 2, state.  TDDFT calculations indicate that the 
quenching arises from the presence of metal-based d orbitals energetically positioned between 
the HOMO and LUMO of the dansyl fluorophore.  Addition of reducing agents to 4 triggers a 
6.3-fold emission turn-on response in aqueous buffer.  Compound 4 therefore has the potential to 
serve as a mechanistic probe to monitor the reduction platinum(IV) complexes in biology.  In 
theory, such a turn-on response should enable both spatial and temporal resolution of the 
platinum(IV) reduction event by fluorescence microscopy.  Unfortunately, the practical 
applicability of this complex in living cells is limited by its low quantum yield in water and the 
rapid rate of reduction.  As a first generation platinum(IV) redox sensor, however, compound 4 
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provides a proof of concept and starting point for the design of more effective sensors of the 
properties of platinum(IV) complexes in biological milieu. 
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